Nuzenio

Trastuzumab Deruxtecan

Trastuzumab Deruxtecan news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 6 publisher sources 100/100 entity strength

Latest news

AstraZeneca receives CDSCO approval of additional indication for trastuzumab deruxtecan - BioSpectrum IndiaBioSpectrum India · Sun, 09 Aug 2026 17:43:21 GMTAfter T-DXd: Why Switching ADC Targets May Not Be Enough - OncodailyOncodaily · Sun, 09 Aug 2026 13:59:31 GMTAndrea Necchi: Trastuzumab Deruxtecan for HER2-Positive Urothelial Cancer Now Available in Italy - OncodailyOncodaily · Sun, 09 Aug 2026 12:03:13 GMTHERTHENA-Breast02 Trial: Innovative Dual-ADC Strategy in HR+/HER2-Low Breast Cancer - OncodailyOncodaily · Sat, 08 Aug 2026 11:14:59 GMTDr Bazhenova on the Optimal Positioning of ADCs in Lung Cancer - OncLiveOncLive · Fri, 07 Aug 2026 19:55:08 GMTPreviously Reported at ASCO 2026, Roswell Park Breast Cancer Analysis Now Published in AMJ Oncology | Newswise - NewswiseNewswise · Fri, 07 Aug 2026 14:05:00 GMTS100–RAGE Inhibition Restored Sensitivity to Treatment in Breast Cancer - Technology NetworksTechnology Networks · Wed, 05 Aug 2026 13:29:54 GMTAstraZeneca/Daiichi’s Enhertu® (Trastuzumab Deruxtecan) + THP Approved in India for HER2-Positive Breast Cancer - Pearce IPPearce IP · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Sun, 09 Aug 2026 17:43:21 GMTAstraZeneca receives CDSCO approval of additional indication for trastuzumab deruxtecan - BioSpectrum India
Sun, 09 Aug 2026 13:59:31 GMTAfter T-DXd: Why Switching ADC Targets May Not Be Enough - Oncodaily
Sun, 09 Aug 2026 12:03:13 GMTAndrea Necchi: Trastuzumab Deruxtecan for HER2-Positive Urothelial Cancer Now Available in Italy - Oncodaily
Sat, 08 Aug 2026 11:14:59 GMTHERTHENA-Breast02 Trial: Innovative Dual-ADC Strategy in HR+/HER2-Low Breast Cancer - Oncodaily
Fri, 07 Aug 2026 19:55:08 GMTDr Bazhenova on the Optimal Positioning of ADCs in Lung Cancer - OncLive
Fri, 07 Aug 2026 14:05:00 GMTPreviously Reported at ASCO 2026, Roswell Park Breast Cancer Analysis Now Published in AMJ Oncology | Newswise - Newswise

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Trastuzumab Deruxtecan.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.